2018-07-12T11:25:33-05:00 2017-12-31 131517563 LOEB & TROPER LLP 655 THIRD AVENUE 12TH FLOOR NEW YORK NY 10017 990 2017-01-01 362883000 AMERICAN LIVER FOUNDATION AMER 2126681000 39 BROADWAY NO 2700 NEW YORK NY 100063003 DAVID TICKER CHIEF FINANCIAL OFFICER 2126681000 2018-07-10 1 AARON SHAPIRO P01333816 2128674000 2017 2022-09-23 18:48:47Z DAVID TICKER 39 BROADWAY NO 2700 NEW YORK NY 100063003 10739899 0 X WWW.LIVERFOUNDATION.ORG X 1976 IL THE MISSION OF AMERICAN LIVER FOUNDATION (ALF) IS TO FACILITATE, ADVOCATE AND PROMOTE EDUCATION, SUPPORT AND RESEARCH FOR THE PREVENTION, TREATMENT AND CURE FOR LIVER DISEASE. 25 24 85 2000 0 0 7306322 6597397 0 0 128520 362665 2241730 2449637 9676572 9409699 287500 350000 0 0 4943416 5261420 0 0 898131 3284858 3309839 8515774 8921259 1160798 488440 5158077 5320791 1952324 1674753 3205753 3646038 X TO FACILITATE, ADVOCATE AND PROMOTE EDUCATION, SUPPORT AND RESEARCH FOR THE PREVENTION, TREATMENT AND CURE FOR LIVER DISEASE. 0 0 1945029 350000 PUBLIC AND PATIENT EDUCATION - SEE SCHEDULE OPUBLIC AND PATIENT EDUCATIONINFORMATION SPECIALISTS ARE AVAILABLE TO ANSWER QUESTIONS ABOUT LIVER DISEASE AND LIVER WELLNESS, INCLUDING RISK FACTORS, PREVENTION, SYMPTOMS, EARLY DETECTION, DIAGNOSIS AND TREATMENT OPTIONS. ALF CAN DIRECT CALLERS TO LOCAL SERVICES IN THEIR AREA, HELP THEM LEARN ABOUT CLINICAL TRIALS AND HELP THEM FIND A PHYSICIAN. INTERPRETATION SERVICES ARE AVAILABLE FOR NON-ENGLISH SPEAKERS. WE ALSO HOST A VIBRANT ONLINE COMMUNITY ACROSS NUMEROUS SOCIAL MEDIA PLATFORMS, AND THREE WEBSITES, INCLUDING 2 DISEASE SPECIFIC MICRO-SITES.IN 2017, ALF LAUNCHED A COMPLETELY REDESIGNED WEBSITE, WWW.LIVERFOUNDATION.ORG THAT IMPROVES USER EXPERIENCE AND SEARCH ENGINE OPTIMIZATION, NAVIGATION, AND USE OF MULTI-MEDIA EDUCATIONAL RESOURCES.THE LIVER LOWDOWN E-NEWSLETTER IS DISSEMINATED TO PROVIDE INFORMATION ABOUT THE PREVENTION, TREATMENT AND CURE OF LIVER DISEASE ABOUT THE FOUNDATION'S EDUCATIONAL AND SIGNATURE PROGRAMS; AN IN-DEPTH FOCUS ON SPECIFIC TYPES OF LIVER DISEASE, AND PROFILES OF LIVER PATIENTS AND CAREGIVERS' PERSONAL EXPERIENCES. IN 2017, APPROXIMATELY 100,000 PEOPLE RECEIVED EACH OF OUR ISSUES.IN CY 2017, OUR HELPLINE ANSWERED 9,173 REQUESTS FOR INFORMATION VIA PHONE, E-CHAT, EMAIL AND "SNAIL MAIL".IN CY 2017, ALF'S WEBSITES RECORDED A COMBINED TOTAL OF OVER TWO MILLION UNIQUE VISITORS. AT THE END OF THE YEAR, WE HAD 148,269 FACEBOOK FANS AND 5,713 TWITTER FOLLOWERS. OUR SUPPORT COMMUNITY ON THE INSPIRE PLATFORM HAD OVER 16,300 MEMBERS. A LIVE "TWEETCHAT" REACHED THOUSANDS WITH A ROBUST CONVERSATION ON PRIMARY BILIARY CHOLANGITIS.IN CY 2017, WE CONTINUED OUR SERIES OF PATIENT EDUCATION WEBINARS. WEBINARS SPONSORED BY OUR DIVISIONS INCLUDE FEATURES ON HEPATITIS C AND INSURANCE COVERAGE, ALCOHOL RELATED HEPATITIS, UNDERSTANDING LIVER ENZYME TESTS, NUTRITION AND THE LIVER, PREVENTION OF FATTY LIVER DISEASE, VACCINATIONS AND LIVER DISEASE, MENTAL HEALTH, FINANCIAL LITERACY, AND LIVER TRANSPLANTATION.ALF EXPANDED ITS EDUCATIONAL RESOURCE LIBRARY BY CREATING UPDATED AND NEW RESOURCES ON HEPATITIS B, ALCOHOL RELATED LIVER DISEASE, NONALCOHOLIC FATTY LIVER DISEASE. MANY OF THESE RESOURCES ARE AVAILABLE IN ENGLISH, CHINESE, KOREAN, VIETNAMESE, RUSSIAN AND SPANISH). ALL BROCHURES ARE AVAILABLE FOR DOWNLOAD FROM OUR WEBSITE AT HTTPS://WWW.LIVERFOUNDATION.ORG/FOR-PATIENTS/RESOURCES/BROCHURES/.ALF'S NATIONAL PATIENT ADVISORY COMMITTEE, MADE UP OF PATIENT ADVOCATES FROM ACROSS THE COUNTRY WITH HEPATITIS C, NAFLD, AND PRIMARY BILIARY CHOLANGITIS, WAS EXPANDED TO INCLUDE PATIENTS WITH ALCOHOL-RELATED LIVER DISEASE. EDUCATIONAL VIDEOS WERE CREATED FEATURING THESE PATIENTS ARE AVAILABLE AT HTTPS://WWW.LIVERFOUNDATION.ORG/FOR-PATIENTS/RESOURCES/VIDEOS/. ALF'S 4TH ANNUAL LIVER CANCER AWARENESS CAMPAIGN REACHED MILLIONS IN TARGETED ADVERTISING IN SAN FRANCISCO, LOS ANGELES, CHICAGO AND NEW YORK, WITH DALLAS AND HOUSTON BEING ADDED THIS YEAR. THE CAMPAIGN HAD NATIONWIDE REACH VIA SOCIAL MEDIA DURING OCTOBER (LIVER CANCER AWARENESS MONTH).OUR PATIENT EDUCATION AND SUPPORT PROGRAM FOR PRIMARY BILIARY CHOLANGITIS (PBC) CONTINUED, UTILIZING TEXT MESSAGING TO PROVIDE A SERIES OF TARGETED MESSAGES TO HELP IMPROVE PATIENT PERCEPTION AND KNOWLEDGE OF THEIR CONDITION. NEARLY 100 PEOPLE PARTICIPATED IN THIS PROGRAM IN 2017.OUR GREAT LAKES DIVISION CONTINUED ITS INITIATIVE TO PROVIDE HEPATITIS C TESTING AND LINKAGE TO CARE TO UNDERSERVED POPULATIONS IN THE CHICAGO AREA. NEARLY 8,000 PEOPLE WERE TESTED IN 2017, WITH ALL THAT TESTED POSITIVE LINKED TO SERVICES TO ASSIST THEM IN OBTAINING TREATMENT. A SIMILAR PROGRAM CALLED CONNECT TEXAS WAS LAUNCHED IN 2017, PROVIDING TESTING AND FOLLOW-UP SCREENING FOR HUNDREDS OF PATIENTS, WITH THE EXPECTATION THAT 3,500 WILL BE TESTED INTO 2018.NEW IN 2017: ALF LAUNCHED "ALCOHOL AND YOUR LIVER," A TWO-YEAR PILOT PROGRAM THAT AIMS TO INCREASE KNOWLEDGE ABOUT LIVER HEALTH, WITH A SPECIAL FOCUS ON ACUTE ALCOHOL RELATED-HEPATITIS AND ITS RELATIONSHIP TO BINGE DRINKING. TARGET AUDIENCES WILL INCLUDE HEALTHCARE PROVIDERS, THE GENERAL PUBLIC, AND AT-RISK POPULATIONS, PARTICULARLY 1). YOUNG PEOPLE WHO ARE LEARNING TO MANAGE THE FREEDOMS AND RESPONSIBILITIES OF ADULTHOOD AND 2). GROUPS OR OTHERS WHO MAY BE PRONE TO BINGE DRINKING. BEGINNING PRESENTATIONS IN LATE 2017, THE PROGRAM REACHED 887 PEOPLE.OUR ASK THE EXPERTS EDUCATIONAL PROGRAM OFFERED PARTICIPANTS ACROSS THE UNITED STATES ACCESS TO HEAR FROM MEDICAL PROFESSIONALS ON A VARIETY OF TOPICS, INCLUDING VIRAL HEPATITIS, FATTY LIVER, LIVER CANCER, NUTRITION, MANAGING YOUR MEDICATIONS AND LIVER WELLNESS. MORE THAN 1,100 PEOPLE PARTICIPATED IN THESE PROGRAMS. 1672242 PATIENT SUPPORT - SEE SCHEDULE OPATIENT SUPPORTALF'S VIRAL HEPATITIS COMMUNITY EDUCATION PROGRAM PROVIDES COMPREHENSIVE AND ACCURATE INFORMATION ABOUT HEPATITIS (A, B, AND C), INCLUDING RISK FACTORS, TRANSMISSION AND PREVENTION, AND AN OVERVIEW OF TREATMENT OPTIONSIN CY 2017, ALF REACHED 6,387 PEOPLE THROUGH THIS IMPORTANT PROGRAM. 1739926 COMMUNITY SERVICES - SEE SCHEDULE OCOMMUNITY SERVICEALF OFFERS SEVERAL COMMUNITY EDUCATION PROGRAMS ON LIVER HEALTH AND LIVER DISEASE THAT ARE INTERACTIVE AND AGE APPROPRIATE. THESE POPULAR PROGRAMS INCLUDE: LOVE YOUR LIVER, LIVER WELLNESS - WHAT EVERYBODY NEEDS TO KNOW AND TEENS TO TWENTIES - LIVER WELLNESS GUIDE. IN ADDITION, ALF PARTICIPATES IN COMMUNITY HEALTH FAIRS AND COALITION MEETINGS TO RAISE AWARENESS OF LIVER DISEASE.IN CY 2017, COMMUNITY EDUCATION PROGRAMS REACHED A COMBINED TOTAL OF 5,322 PEOPLE NATIONWIDE, AND HEALTH FAIRS/OUTREACH REACHED 18,004 PEOPLE.ALF PARTICIPATES IN FEDERAL, STATE AND LOCAL ADVOCACY EFFORTS TO ADDRESS THE NEEDS OF PEOPLE AFFECTED BY LIVER DISEASE AND THAT FOCUS ON LARGER HEALTHCARE ISSUES TO IMPROVE LIVER HEALTH AND INCREASE RESEARCH FUNDING.IN CY 2017, ALF LENT ITS NAME TO COMMUNITY SIGN-ON LETTERS PROMOTING IMPROVEMENTS TO HEPATITIS TESTING POLICY AND ACCESS TO CARE; PARTICIPATED IN COALITIONS WITH VARIOUS OTHER PATIENT ADVOCACY GROUPS TO URGE INCREASED FUNDING FOR THE NIH, CDC, VA, AND DOD; DISTRIBUTED "CALLS TO ACTION" FOR OUR COMMUNITY TO CONTACT THEIR ELECTED OFFICIALS REGARDING A VARIETY OF ISSUES RELATING TO LIVER DISEASE; HOSTED AND EDUCATION AND ADVOCACY DAY IN WASHINGTON, DC THAT INCLUDED 40 PATIENT ADVOCATES REPRESENTING MULTIPLE DISEASE STATES; AND BROUGHT PATIENT ADVOCATES TO LIVER HILL DAY WITH THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASE AND THE DIGESTIVE DISEASES NATIONAL COALITION. 1742722 RESEARCHSINCE 1979, OUR RESEARCH AWARDS PROGRAM HAS AWARDED OVER $26 MILLION FOR RESEARCH. MORE THAN 850 SCIENTISTS AND PHYSICIANS HAVE BROADENED THE UNDERSTANDING OF THE LIVER, DISCOVERED NEW WAYS TO TREAT PATIENTS, PUBLISHED NEARLY 30,000 SCIENTIFIC JOURNAL ARTICLES AND SECURED OVER 200 PRESTIGIOUS NATIONAL INSTITUTES OF HEALTH GRANTS TO FURTHER ADVANCE THE SCIENTIFIC STUDY OF LIVER HEALTH AND LIVER DISEASE.IN CY 2017, ALF ANNOUNCED THE RECIPIENTS OF THE 2017 RESEARCH AWARDS PROGRAM, 1 LIVER SCHOLAR AND 10 POST-DOCTORAL RESEARCH FELLOWSHIPS. THESE ELEVEN SCIENTISTS REPRESENT ELEVEN MEDICAL AND RESEARCH INSTITUTIONS AND WERE AWARDED $200,000 TO SUPPORT THEIR RESEARCH IN THE AREAS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), LIVER CANCER, LIVER TRANSPLANT, ALCOHOL-RELATED HEPATITIS, ACUTE -ON-CHRONIC LIVER FAILURE, VIRAL HEPATITIS, AND NON-ALCOHOLIC STEATOHEPATITIS (NASH).PROFESSIONAL EDUCATIONALF PROVIDES EDUCATION TO HEALTHCARE PROFESSIONALS CONCERNING MEDICAL KNOWLEDGE AND PROCEDURES USED TO PREVENT, TREAT, AND CURE LIVER DISEASE THROUGH REGIONAL EVENTS INCLUDING: EDUCATIONAL PROGRAMS FOR MEDICAL ADVISORS IN CONNECTICUT (149 PARTICIPANTS); LIVER CANCER CONSORTIUM AND ACADEMIC DEBATES IN CHICAGO (286 PROFESSIONALS); LIVER MATTERS CONFERENCE AND CITYWIDE "LIVER ROUNDS" PROGRAMS IN CLEVELAND (293 PROFESSIONALS); MASSACHUSETTS OPIOID CONFERENCE (113 PROFESSIONALS); MAINE OPIOID CONFERENCE (63 PROFESSIONALS); 27TH ANNUAL ARIAS SYMPOSIUM IN CAMBRIDGE (142 PROFESSIONALS); HEPATITIS C TREATMENT FOR PRIMARY CARE PROVIDERS IN MANHATTAN, FATTY LIVER SCREENING DIAGNOSIS AND TREATMENT IN WESTCHESTER COUNTY (94 PROFESSIONALS); HIGHLIGHTS FROM THE AASLD ANNUAL LIVER MEETING IN DES MOINES (24 PROFESSIONALS), CEDAR RAPIDS (32 PROFESSIONALS), MINNESOTA (65 PROFESSIONALS) AND WISCONSIN (31 PROFESSIONALS); CASE STUDIES CONFERENCE IN MINNESOTA (48 PARTICIPANTS). 1742722 7099919 1 1 0 0 0 0 0 0 1 1 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 292 0 85 1 0 0 0 0 0 1 1 0 0 0 0 X 25 24 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WI WY X X DAVID TICKER 2126681000 39 BROADWAY SUITE 2700 NEW YORK NY 100063003 THOMAS F NEALON III CHIEF EXECUTIVE OFFICER 20.00 X X 52000 0 0 DANIEL E WEIL TREASURER 0.30 X X 0 0 0 NICHOLAS J DEROMA CHAIRMAN OF THE BOARD OF DIRECTORS 0.30 X X 0 0 0 JUSTIN TODD ALLEN BOARD MEMBER 0.30 X 0 0 0 HAMILTON BAIDEN BOARD MEMBER 0.30 X 0 0 0 JODI BOHR BOARD MEMBER 0.30 X 0 0 0 MIKE BRAUNSTEIN BOARD MEMBER 0.30 X 0 0 0 ROBERT BRICKMAN BOARD MEMBER 0.30 X 0 0 0 EUGENE CAUTILLO BOARD MEMBER 0.30 X 0 0 0 BRIAN CHRISTIE BOARD MEMBER 0.30 X 0 0 0 EDGAR DELGADO BOARD MEMBER 0.30 X 0 0 0 ALLAN J DOERR BOARD MEMBER 0.30 X 0 0 0 T CLARK GAMBLIN MD MS BOARD MEMBER 0.30 X 0 0 0 MICHAEL KERR BOARD MEMBER 0.30 X 0 0 0 ELIZABETH LEESMANN BOARD MEMBER 0.30 X 0 0 0 ROBERT LEVENTHAL MD FACP AGAF BOARD MEMBER 0.30 X 0 0 0 ROHIT LOOMBA MD MH SC BOARD MEMBER 0.30 X 0 0 0 ROBERT MEROWITZ BOARD MEMBER 0.30 X 0 0 0 EDDIE CHEUNG MD FACG BOARD MEMBER 0.30 X 0 0 0 NICOLE SMITH PHD BOARD MEMBER 0.30 X 0 0 0 SUSAN SHERMAN STONE CPA MST BOARD MEMBER 0.30 X 0 0 0 GUY THOMAS BOARD MEMBER 0.30 X 0 0 0 HILLEL TOBIAS MD PHD BOARD MEMBER 0.30 X 0 0 0 TRACI TIGUE BOARD MEMBER 3.00 X 0 0 0 ROCKY YAPP MD MPH AGAF BOARD MEMBER 0.30 X 0 0 0 DAVID TICKER CHIEF FINANCIAL OFFICER 35.00 X 182516 0 21664 LYNN SEIM CHIEF OPERATING OFFICER 35.00 X 188562 0 6734 JOANN THOMPSON NATIONAL DIR OF DIVISIONS AND CONT. ED. 35.00 X 150808 0 2697 ERIKA GOODMAN NATIONAL DIR OF DEVELOPMENT 35.00 X 143538 0 14600 VERONICA PEREZ EXCEUTIVE DIRECTOR 35.00 X 128149 0 19634 KATHLEEN FLYNN EXCEUTIVE DIRECTOR 35.00 X 124701 0 10793 GAIL FAVREAU EXECUTIVE DIRECTOR 35.00 X 122943 0 12453 1093217 0 88575 11 0 1 0 JONES PUBLIC AFFAIRS 1420 K ST NW STE 1050 WASHINGTON DC 20005 COMMUNICATION 155212 AMPLOTECH INC PO BOX 16422 SAN JUAN PR 00908 WEBSITE DESIGN AND MAINTENANCE 145878 2 23648 2695859 3877890 1336 6597397 55931 55931 779745 473011 306734 306734 306734 3280832 2695859 857189 2423643 2423643 OTHER 900099 25994 25994 25994 9409699 0 0 2812302 225000 225000 125000 125000 451476 362769 48921 39786 4087750 3284578 442939 360233 21163 17005 2293 1865 356230 286237 38600 31393 344801 277053 37362 30386 291 291 51200 51200 15605 15605 717324 645865 71459 278647 264039 444 14164 413117 177933 122732 112452 260140 208951 28159 23030 649516 521694 70335 57487 393931 334199 21446 38286 6904 6904 55956 44962 6063 4931 42940 34494 4652 3794 HOTEL AND CATERING EXPE 304269 229459 4330 70480 119999 60681 20933 38385 8921259 7099919 923209 898131 1344390 1458383 229776 68499 857931 934485 244797 288229 1307710 1191288 162082 116422 2319101 2454773 5158077 5320791 515037 528691 137500 175000 808606 801234 300000 191181 169828 1952324 1674753 X -275929 -299628 2489647 2953631 992035 992035 3205753 3646038 5158077 5320791 488440 -55888 7733 0 X X 0 1 X 1 0 X 8029381 7402572 1318021 7306322 6597397 30653693 8029381 7402572 1318021 7306322 6597397 30653693 4578498 26075195 47711 60575 28795 52306 55931 245318 242554 2423643 2666197 10762 711 15001 25994 52468 33617676 3046 0.77560 0.88710 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2014 AMOUNT: $ 10,762. 2015 AMOUNT: $ 711. 2016 AMOUNT: $ 15,001. 2017 AMOUNT: $ 25,994. PART II AMERICAN LIVER FOUNDATION CHANGED THEIR YEAR-END IN 2015 FROM SEPTEMBER 30 TO DECEMBER 31. THE DATA IN 2015 REPRESENTS THE 3 MONTHS ENDED DECEMBER 31, 2015. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 X 1103423 174960 62500 1215883 1095696 57727 50000 1103423 1073159 22537 1095696 1142761 5398 75000 1073159 1091429 84671 33339 1142761 0.81600 0.18400 0 0 97448 90958 6490 462752 441711 21041 747510 658619 88891 116422 DEFERRED RENT 169828 169828 X 9345939 -55888 7733 -48155 9394094 15605 15605 9409699 8905654 0 8905654 15605 15605 8921259 PART IV, LINE 2B: FUNDS HELD ON BEHALF OF OTHERS - ALF ACTS AS AN ADMINISTRATOR FOR FUNDS COLLECTED ON BEHALF OF LIVER TRANSPLANT PATIENTS. ALF DISBURSES FUNDS TO COVER THE COST OF PROPERLY DOCUMENTED POST-SURGERY EXPENSES PART V, LINE 4: INTENDED USE OF ENDOWMENT FUNDS HAS BEEN SPECIFIED BY THE DONOR. ALL FUNDS ON HAND ARE USED TO GENERATE INTEREST/DIVIDEND INCOME AND CAPITAL GAINS TO SUPPORT VARIOUS RESEARCH INITIATIVES. PART X, LINE 2: ALF HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. PERIODS ENDING DECEMBER 31, 2014 AND SUBSEQUENT REMAIN SUBJECT TO REVIEW BY APPLICABLE TAXING AUTHORITIES. CHALLENGE CAMPAIGN 837008 837008 39723 33651 GALA 434619 318369 116250 7652 78199 300 3505 70 4705064 1540482 3164582 131520 453396 31703 77540 5976691 2695859 3280832 139172 571318 32003 114696 857189 2423643 0 REGENTS OF THE UNIVERSITY OF MICHIGAN 5082 WOLVERINE TOWER 3003 SOUTH STATE ST ANN ARBOR MI 481091287 386006309 501C3 75000 RESEARCH GRANT TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3451 WALNUT ST PHILADELPHIA PA 19104 231352685 501C3 75000 RESEARCH GRANT REGENTS OF UNIVERSITY OF CALIFORNIA-UC SAN DIEGO 9500 GILMAN DR LA JOLLA CA 92093 956006144 501C3 75000 RESEARCH GRANT 3 0 POST DOCTORATE AWARD 10 125000 X X X 0 0 0 0 0 0 0 0 0 DAVID TICKER CHIEF FINANCIAL OFFICER 182516 0 0 0 0 0 1873 0 19791 0 204180 0 0 0 LYNN SEIM CHIEF OPERATING OFFICER 188562 0 0 0 0 0 1873 0 4861 0 195296 0 0 0 JOANN THOMPSON NATIONAL DIR OF DIVISIONS AND CONT. 150808 0 0 0 0 0 1465 0 1232 0 153505 0 0 0 ERIKA GOODMAN NATIONAL DIR OF DEVELOPMENT 143538 0 0 0 0 0 1386 0 13214 0 158138 0 0 0 MICHAEL KERR BOARD MEMBER WORKING CAPITAL X 300000 0 1 1 FORM 990, PART VI, SECTION B, LINE 11B A DRAFT OF THE FORM 990 IS SENT TO THE FINANCE COMMITTEE FOR REVIEW AND COMMENTS IN THE MONTHLY MEETING PRIOR TO FILING. IN ADDITION, A DRAFT OF THE FORM 990 IS ALSO SENT TO EACH BOARD MEMBER FOR DISCUSSION. AFTER QUESTIONS AND COMMENTS ARE ADDRESSED AND THE FORM 990 IS APPROVED, IT IS READY FOR FILING. FORM 990, PART VI, SECTION B, LINE 12C ANNUALLY, OUR CONFLICT OF INTEREST FORM IS COMPLETED BY OFFICERS AND DIRECTORS. THE FORM MUST INDICATE ANY POSSIBLE CONFLICTS OF INTEREST AND BE SIGNED BY ALL OFFICERS AND DIRECTORS. WHEN ANY SUCH CONFLICT OF INTEREST IS RELEVANT TO A MATTER REQUIRING ACTION BY THE BOARD, THE INTERESTED PERSON SHALL CALL IT TO THE ATTENTION OF THE BOARD AND SUCH PERSON SHALL NOT VOTE ON THE MATTER. MOREOVER, THE PERSON HAVING A CONFLICT SHALL RETIRE FROM THE ROOM IN WHICH THE BOARD IS MEETING AND SHALL NOT PARTICIPATE IN THE FINAL DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. HOWEVER, THAT PERSON SHALL PROVIDE THE BOARD WITH ANY AND ALL RELEVANT INFORMATION. THE MINUTES OF THE MEETING OF THE BOARD, SHALL REFLECT THAT THE CONFLICT OF INTEREST WAS DISCLOSED AND THAT THE INTERESTED PERSON WAS NOT PRESENT DURING THE FINAL DISCUSSION OR VOTE AND DID NOT VOTE. WHEN THERE IS A DOUBT AS TO WHETHER A CONFLICT OF INTEREST EXISTS, THE MATTER SHALL BE RESOLVED BY A VOTE OF THE BOARD. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE REVIEWED TWO EXTERNAL SALARY SURVEYS SPECIFIC TO THE NEW YORK MARKET. FROM TIME TO TIME, ALF PARTICIPATES IN EXTERNAL SURVEYS, THE TWO MOST RECENT (2016), THE FOUNDATION CENTER SALARY SURVEY AND PROFESSIONALS FOR NON PROFIT SALARY SURVEY. THE BOARD OF DIRECTORS DETERMINED THE COMPENSATION AMOUNTS BASED ON REVIEW OF THESE SURVEY RESULTS AND THE OFFICERS AND KEY EMPLOYEES' PERFORMANCE FOR THE YEAR. THE COMPENSATION AMOUNTS WERE DISCUSSED AND APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 ALL OF THE ITEMS DESCRIBED ARE AVAILABLE ON OUR MAIN WEBSITE AT WWW.LIVERFOUNDATION.ORG FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED SINCE PRIOR YEAR.